Latest Pharmaceuticals Biotechnology Life Sciences News

Page 1 of 1

Starpharma Raises $32 Million to Advance DEP® HER2-Lutetium Trial

Starpharma launches a fully underwritten $32 million entitlement offer to fund the Phase 1 trial of its DEP® HER2-Lutetium radiopharmaceutical and accelerate its targeted oncology asset development.

Ada Torres

15 July 2026

Top